114 related articles for article (PubMed ID: 16087811)
1. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes.
Bhatt DL; Topol EJ
Circulation; 2005 Aug; 112(6):906-15; discussion 923. PubMed ID: 16087811
[No Abstract] [Full Text] [Related]
2. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes.
Cutlip DE; Kuntz RE
Circulation; 2005 Aug; 112(6):916-22; discussion 922. PubMed ID: 16092153
[No Abstract] [Full Text] [Related]
3. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
[TBL] [Abstract][Full Text] [Related]
4. Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric: a report from the National Cardiovascular Data Registry (NCDR).
Wang TY; Peterson ED; Dai D; Anderson HV; Rao SV; Brindis RG; Roe MT;
J Am Coll Cardiol; 2008 May; 51(21):2068-74. PubMed ID: 18498965
[No Abstract] [Full Text] [Related]
5. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
[TBL] [Abstract][Full Text] [Related]
6. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
Porto I; Van Gaal W; Banning A
Eur Heart J; 2005 Oct; 26(20):2206; author reply 2206-7. PubMed ID: 16087650
[No Abstract] [Full Text] [Related]
7. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
[TBL] [Abstract][Full Text] [Related]
8. Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
Linefsky JP; Lin M; Pieper KS; Reist CJ; Berdan LG; Antman EM; Goodman SG; French JK; Guneri S; Roe MT; Newby LK; Harrington RA; Ferguson JJ; Califf RM; Mahaffey KW
Am J Cardiol; 2009 Nov; 104(10):1330-5. PubMed ID: 19892046
[TBL] [Abstract][Full Text] [Related]
9. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
[TBL] [Abstract][Full Text] [Related]
10. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
Celik T; Iyisoy A; Yuksel CU; Kilic S; Yilmaz MI; Akgul EO; Jata B; Isik E
Coron Artery Dis; 2008 Dec; 19(8):543-9. PubMed ID: 19005288
[TBL] [Abstract][Full Text] [Related]
11. Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence.
Valente S; Lazzeri C; Saletti E; Chiostri M; Gensini GF
J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1083-7. PubMed ID: 18852577
[TBL] [Abstract][Full Text] [Related]
12. Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions.
Natarajan MK; Kreatsoulas C; Velianou JL; Mehta SR; Pericak D; Goodhart DM
Am J Cardiol; 2004 Mar; 93(6):750-3. PubMed ID: 15019884
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
[TBL] [Abstract][Full Text] [Related]
14. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
[TBL] [Abstract][Full Text] [Related]
15. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality.
Prasad A; Singh M; Lerman A; Lennon RJ; Holmes DR; Rihal CS
J Am Coll Cardiol; 2006 Nov; 48(9):1765-70. PubMed ID: 17084247
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of creatine kinase release after percutaneous coronary intervention.
Cavallini C; Rugolotto M; Savonitto S
Ital Heart J; 2005 Jun; 6(6):522-9. PubMed ID: 16008158
[TBL] [Abstract][Full Text] [Related]
17. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
[TBL] [Abstract][Full Text] [Related]
18. Myocardial damage in successful single vessel coronary angioplasty as assessed by creatinine kinase and its myocardium band isoenzyme levels.
Abbas S; Tayyab F; Samor NA; Shabir M; Kayani AM
J Coll Physicians Surg Pak; 2008 Mar; 18(3):142-6. PubMed ID: 18460240
[TBL] [Abstract][Full Text] [Related]
19. In ST-Elevation myocardial infarction patients receiving primary percutaneous coronary intervention, admission cardiac troponin T and peak cardiac troponin T values differ in their prognostic properties.
Hallén J; Atar D
Am J Cardiol; 2009 May; 103(9):1331. PubMed ID: 19406285
[No Abstract] [Full Text] [Related]
20. Naproxen treatment prevents periprocedural inflammatory response but not myocardial injury after percutaneous coronary intervention.
Ozdol C; Gulec S; Rahimov U; Atmaca Y; Turhan S; Erol C
Thromb Res; 2007; 119(4):453-9. PubMed ID: 17157900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
